NO20014841D0 - Anti-HIV-1 vaksine som omfatter hele eller del av HIV-1 TAT proteinet - Google Patents

Anti-HIV-1 vaksine som omfatter hele eller del av HIV-1 TAT proteinet

Info

Publication number: NO20014841D0
Authority: NO; Norway
Prior art keywords: hiv; vaccine; protein; tat protein; tat
Prior art date: 1999-04-13

Application number

NO20014841A

Other languages

English (en)

Other versions

NO326603B1 (no

NO20014841L (no

Inventor

Erwann Loret

Original Assignee

Centre Nat Rech Scient

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-13

Filing date

2001-10-04

Publication date

2001-10-04

1999-04-13 Priority claimed from FR9904610A external-priority patent/FR2792204B1/fr

2001-10-04 Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient

2001-10-04 Publication of NO20014841D0 publication Critical patent/NO20014841D0/no

2001-11-27 Publication of NO20014841L publication Critical patent/NO20014841L/no

2009-01-19 Publication of NO326603B1 publication Critical patent/NO326603B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
- C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
- C12N2740/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/974—Aids related test
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Mycology (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Hematology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Tropical Medicine & Parasitology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
AIDS & HIV (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20014841A 1999-04-13 2001-10-04 Anti-HIV-1 vaksine som omfatter et HIV-1 TAT Oyi protein eller ekspressjonsvektor omfattende nukleotidsekvens som koder for variantproteinet og fremgangsmate for fremstilling av anti-Tat polyklonale antistoffer og fremstilling av Tat-varianten NO326603B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR9904610A FR2792204B1 (fr)	1999-04-13	1999-04-13	Vaccin anti-vih-1 comprenant tout en partie de la proteine tat de vih-1
FR9916633A FR2792206B1 (fr)	1999-04-13	1999-12-29	Vaccin anti-vih-1 comprenant tout ou partie de la proteine tat de vih-1
PCT/FR2000/000938 WO2000061067A2 (fr)	1999-04-13	2000-04-12	Vaccin anti-vih-1 comprenant tout ou partie de la proteine tat de vih-1

Publications (3)

Publication Number	Publication Date
NO20014841D0 true NO20014841D0 (no)	2001-10-04
NO20014841L NO20014841L (no)	2001-11-27
NO326603B1 NO326603B1 (no)	2009-01-19

Family

ID=26234914

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20014841A NO326603B1 (no)	1999-04-13	2001-10-04	Anti-HIV-1 vaksine som omfatter et HIV-1 TAT Oyi protein eller ekspressjonsvektor omfattende nukleotidsekvens som koder for variantproteinet og fremgangsmate for fremstilling av anti-Tat polyklonale antistoffer og fremstilling av Tat-varianten

Country Status (20)

Country	Link
US (1)	US7087377B2 (no)
EP (1)	EP1169057B1 (no)
JP (1)	JP4860823B2 (no)
KR (1)	KR100725637B1 (no)
AT (1)	ATE280586T1 (no)
AU (1)	AU775560B2 (no)
BR (1)	BR0009758A (no)
CA (1)	CA2370563C (no)
DE (1)	DE60015312T2 (no)
DK (1)	DK1169057T3 (no)
ES (1)	ES2231178T3 (no)
FR (1)	FR2792206B1 (no)
HK (1)	HK1044463B (no)
HU (1)	HUP0200841A2 (no)
IL (2)	IL145884A0 (no)
MX (1)	MXPA01010482A (no)
NO (1)	NO326603B1 (no)
PL (1)	PL197666B1 (no)
PT (1)	PT1169057E (no)
WO (1)	WO2000061067A2 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100465589B1 (ko) *	2001-04-20	2005-01-13	허만욱	비만 억제 폴리펩타이드
FR2868318B1 (fr) *	2004-04-01	2012-11-16	Commissariat Energie Atomique	Antigene tat stabilise et ses applications pour la vaccination anti-vih
HRP20140819T1 (hr) *	2008-04-22	2014-10-24	Université D'aix-Marseille	MUTIRANI TAT OYI PROTEIN ZA PREVENCIJU ILI LIJEÄŚENJE AIDS-a
CN102405057B (zh) *	2009-03-23	2016-05-25	那尼尔科斯治疗公司	用免疫刺激性Hiv Tat衍生物多肽治疗癌症
AU2011230619C1 (en)	2010-03-25	2016-06-23	Oregon Health & Science University	CMV glycoproteins and recombinant vectors
WO2011128720A1 (en) *	2010-04-14	2011-10-20	Mymetics Corporation	Trans-activator of transcription protein
PL2691530T3 (pl)	2011-06-10	2019-02-28	Oregon Health & Science University	Glikoproteiny i rekombinowane wektory CMV
US20130189754A1 (en)	2011-09-12	2013-07-25	International Aids Vaccine Initiative	Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
EP2586461A1 (en)	2011-10-27	2013-05-01	Christopher L. Parks	Viral particles derived from an enveloped virus
EP2679596B1 (en)	2012-06-27	2017-04-12	International Aids Vaccine Initiative	HIV-1 env glycoprotein variant
US9878001B2 (en)	2012-12-06	2018-01-30	Pin Pharma, Inc.	Immunosuppressive Tat derivative polypeptides
EP2848937A1 (en)	2013-09-05	2015-03-18	International Aids Vaccine Initiative	Methods of identifying novel HIV-1 immunogens
CN105705164A (zh)	2013-10-04	2016-06-22	品诺制药公司	用于癌症治疗的免疫刺激性hiv tat衍生多肽
US10058604B2 (en)	2013-10-07	2018-08-28	International Aids Vaccine Initiative	Soluble HIV-1 envelope glycoprotein trimers
EP3069730A3 (en)	2015-03-20	2017-03-15	International Aids Vaccine Initiative	Soluble hiv-1 envelope glycoprotein trimers
EP3072901A1 (en)	2015-03-23	2016-09-28	International Aids Vaccine Initiative	Soluble hiv-1 envelope glycoprotein trimers

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4281061A (en) *	1979-07-27	1981-07-28	Syva Company	Double antibody for enhanced sensitivity in immunoassay
US5019510A (en)	1987-10-28	1991-05-28	Institut Pasteur	Isolation, molecular cloning and sequencing of an HIV-1 isolate from a Gabonese donor
US5132205A (en) *	1988-10-07	1992-07-21	Eastman Kodak Company	High ph extraction composition and its use to determine a chlamydial, gonococcal or herpes antigen
US5461029A (en) *	1992-04-24	1995-10-24	American Cyanamid Company	Method of treating herpes viral infections using HBNF and MK proteins
FR2700169B1 (fr) *	1993-01-04	1995-03-24	Transgene Sa	Nouveaux variants trans-dominants TAT du virus de l'immunodéficience humaine.
CA2215483C (fr) *	1995-03-08	2012-01-03	Jean-Francois Zagury	Immunogenes denues de toxicite derivant d'une proteine de regulation retrovirale, anticorps, procede de preparation et compositions pharmaceutiques les renfermant
DE19514089C2 (de) *	1995-04-13	1997-07-10	Deutsches Krebsforsch	Nachweisverfahren für HIV-TAT
JPH10212300A (ja) *	1996-11-26	1998-08-11	Sankyo Co Ltd	ペプチドワクチン
US5891994A (en) *	1997-07-11	1999-04-06	Thymon L.L.C.	Methods and compositions for impairing multiplication of HIV-1

1999
- 1999-12-29 FR FR9916633A patent/FR2792206B1/fr not_active Expired - Lifetime
2000
- 2000-04-12 DK DK00918952T patent/DK1169057T3/da active
- 2000-04-12 DE DE60015312T patent/DE60015312T2/de not_active Expired - Lifetime
- 2000-04-12 PL PL353033A patent/PL197666B1/pl unknown
- 2000-04-12 AU AU39724/00A patent/AU775560B2/en not_active Expired
- 2000-04-12 PT PT00918952T patent/PT1169057E/pt unknown
- 2000-04-12 HK HK02105105.9A patent/HK1044463B/zh not_active IP Right Cessation
- 2000-04-12 JP JP2000610400A patent/JP4860823B2/ja not_active Expired - Lifetime
- 2000-04-12 EP EP20000918952 patent/EP1169057B1/fr not_active Expired - Lifetime
- 2000-04-12 IL IL14588400A patent/IL145884A0/xx active IP Right Grant
- 2000-04-12 CA CA2370563A patent/CA2370563C/fr not_active Expired - Lifetime
- 2000-04-12 HU HU0200841A patent/HUP0200841A2/hu unknown
- 2000-04-12 BR BR0009758-6A patent/BR0009758A/pt not_active Application Discontinuation
- 2000-04-12 MX MXPA01010482A patent/MXPA01010482A/es active IP Right Grant
- 2000-04-12 ES ES00918952T patent/ES2231178T3/es not_active Expired - Lifetime
- 2000-04-12 WO PCT/FR2000/000938 patent/WO2000061067A2/fr not_active Application Discontinuation
- 2000-04-12 AT AT00918952T patent/ATE280586T1/de active
2001
- 2001-10-04 NO NO20014841A patent/NO326603B1/no not_active IP Right Cessation
- 2001-10-11 IL IL145884A patent/IL145884A/en not_active IP Right Cessation
- 2001-10-12 KR KR10-2001-7013031A patent/KR100725637B1/ko not_active Expired - Lifetime
2004
- 2004-10-21 US US10/969,191 patent/US7087377B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CA2370563C (fr)	2013-12-17
IL145884A0 (en)	2002-07-25
EP1169057A2 (fr)	2002-01-09
PL197666B1 (pl)	2008-04-30
CA2370563A1 (fr)	2000-10-19
NO326603B1 (no)	2009-01-19
WO2000061067A2 (fr)	2000-10-19
US7087377B2 (en)	2006-08-08
DK1169057T3 (da)	2005-03-07
HK1044463A1 (en)	2002-10-25
FR2792206B1 (fr)	2006-08-04
NO20014841L (no)	2001-11-27
AU775560B2 (en)	2004-08-05
PL353033A1 (en)	2003-10-06
MXPA01010482A (es)	2002-09-18
EP1169057B1 (fr)	2004-10-27
WO2000061067A3 (fr)	2001-03-29
IL145884A (en)	2007-09-20
DE60015312T2 (de)	2006-02-09
JP4860823B2 (ja)	2012-01-25
ATE280586T1 (de)	2004-11-15
WO2000061067B1 (fr)	2001-05-10
ES2231178T3 (es)	2005-05-16
PT1169057E (pt)	2005-03-31
US20050106161A1 (en)	2005-05-19
KR20020005675A (ko)	2002-01-17
HK1044463B (zh)	2005-06-03
HUP0200841A2 (en)	2002-07-29
DE60015312D1 (de)	2004-12-02
FR2792206A1 (fr)	2000-10-20
AU3972400A (en)	2000-11-14
KR100725637B1 (en)	2007-06-07
JP2002541165A (ja)	2002-12-03
BR0009758A (pt)	2002-01-08

Publication	Publication Date	Title
NO20014841D0 (no)	2001-10-04	Anti-HIV-1 vaksine som omfatter hele eller del av HIV-1 TAT proteinet
TR200001553T2 (tr)	2000-11-21	HIV-1 Tat veya bunun türevleri.
ATE264914T1 (de)	2004-05-15	Antivirale proteine, dafür kodierende dna, und deren verwendung
TR199801418T2 (xx)	1998-10-21	Rekombinant a�� vekt�rleri kar��m�.
BR0108210A (pt)	2002-10-22	Vacina contra o vìrus da imunodeficiência humana
EA200200724A1 (ru)	2003-02-27	Вакцина для профилактической или терапевтической иммунизации против вируса иммунодефицита человека (вич)
WO1990015066A3 (fr)	1991-04-18	Sequences nucleotidiques issues du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications notamment pour l'amplification des genomes de ces retrovirus et pour le diagnostic in vitro des infections dues a ces virus
ES2194029T3 (es)	2003-11-16	Variantes del virus hiv-2.
CY1109659T1 (el)	2014-08-13	Mva που εκφραζει τροποποιημενα γονιδια φακελλου, gag και pol του ιου hiv
SI0887427T1 (sl)	2006-06-30	Pomnozevanje in detekcija HIV-1 in/ali HIV-2
FR2731013B1 (fr)	1997-05-16	Vih-1 de groupe o, fragments desdits virus, ainsi que leurs applications
DK0813542T3 (da)	2003-02-17	Aminosyrehydroxyethylaminosulfonamid som retrovirale proteaseinhibitorer
BR9607625A (pt)	1999-06-15	Inibidores de protease retroviral sulfonamida hidroxietilamino de aminoácido heterociclocarbonila
TR200102024T2 (tr)	2001-12-21	Yeni tedavi.
EA200500533A1 (ru)	2005-12-29	Пептидные производные - ингибиторы слияния при вич-инфекции
MX9700414A (es)	1998-05-31	Agentes antivirales de difluoroestatona.
CY1105629T1 (el)	2010-12-22	Πολυπεπτιδιο που επαγει αντισωματα εξουδετερωσης του ηιv
MX9700044A (es)	1997-04-30	Combinacion triple anti-virus de inmunodeficiencia humana.
ES2104695T3 (es)	1997-10-16	Induccion de proteccion contra una infeccion virica.
UA41338C2 (uk)	2001-09-17	Спосіб інгібування ретровірусної інфекції, яка викликана вірусом імунодефіциту людини (віл), спосіб інгібування вірусу імунодефіциту людини (віл)
ES2095899T3 (es)	1997-03-01	Peptidos de la proteina gag de vih, su preparacion y uso.
BR0108723A (pt)	2002-12-03	Medicamentos contra doenças viróticas
ZA200108398B (en)	2002-09-25	Anti-HIV-1 vaccine comprising all or part of the HIV-1 Tat protein.
BR0109345A (pt)	2002-12-17	Compostos com atividade anti-hiv
BR0207931A (pt)	2004-03-02	Anticorpos naturais ativos contra vìrus hiv

Legal Events

Date	Code	Title	Description
2020-05-11	MK1K	Patent expired